A report on CCSVI treatment research is published in a Neurology Journal. Progress.


Neurology Reviews : Society of Interventional Radiology, 37th Annual Meeting, San Francisco
www.neurologyreviews.com
PrA minimally invasive endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI) is safe and may produce “significant,” short-term improvement in the physical– and mental health–related quality of life in patients with multiple sclerosis (MS), according to researchers.